Single-cell sequencing offers new opportunities to study diseases at a cellular level. Researchers can now study individual cells within complex systems and gain detailed insights into cellular function, communication, and changes across various conditions.
In this webinar, we explore how single-cell sequencing can be applied to understand the cellular dynamics of type 2 diabetes (T2D) and central nervous system (CNS) neoplasms like brain tumors and leptomeningeal disease (LMD). Attendees will gain practical knowledge about these approaches, how they contribute to identifying molecular changes across disease states, and their potential to advance treatment strategies.
You will learn about:
- How single-cell sequencing helps elucidate immune responses and cellular changes in disease
- The role of cerebrospinal fluid analysis and pancreatic islet transcriptomics in deciphering disease biology
- Insights into how cerebrospinal fluid immune profiles reflect tumor microenvironments in CNS lymphoma, glioblastoma, and brain metastases
- How single-cell transcriptomics can be used to identify molecular changes in pancreatic islets during T2D progression
- The ways these approaches advance biomarker identification and drug discovery and development
- Single-cell sequencing
- Disease research
- Biomarker identification
- Immunology, neurology, or metabolic diseases